Global sterilisation monitoring market to value $913mn by 2027
Market research suggests the biological indicators segment will retain the largest share of the global sterilisation monitoring market through 2027.
List view / Grid view
Market research suggests the biological indicators segment will retain the largest share of the global sterilisation monitoring market through 2027.
Over 90 percent of packages at three companies met all of the Drug Supply Chain Security Act (DSCSA) labelling requirements in 2020, despite there being three years until the final deadline.
A multi-company system to improve traceability of pharmaceutical products is newly supported by the FDA.